US2009275664A1PendingUtilityA1
Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
Est. expiryApr 30, 2019(expired)· nominal 20-yr term from priority
A61P 35/00A61P 43/00C07C 211/18C07D 493/04A61P 15/00C07D 207/34C07D 311/92C07D 235/18C07D 295/185A61K 38/00C07K 7/06C07C 2601/02C07D 219/10C07D 307/79A61K 47/65C07C 67/343A61P 13/08C07D 317/70C07K 5/1013C07D 307/92C07C 211/13C07C 45/46
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as prostate-specific antigen (PSA) and cathepsin B are provided, as well as compositions comprising these conjugates. Methods of using these conjugates in the treatment of prostate diseases are also provided.
Claims
exact text as granted — not AI-modified1 - 46 . (canceled)
47 . A compound selected from the group consisting of
and all pharmaceutically-suitable salts and stereoisomers thereof.
48 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
49 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
50 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
51 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
52 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
53 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
54 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
55 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
56 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
57 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
58 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
59 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
60 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
61 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
62 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
63 . A compound of claim 47 of the formula:
or a pharmaceutically-suitable salt or a stereoisomer thereof.
64 . A method of treating cancer, comprising administering to an individual a therapeutic amount of one or more of the compounds of claim 47 , or a pharmaceutically-suitable salt or stereoisomer thereof.
65 . The method of claim 64 , wherein the cancer is prostate cancer.
66 . The method of claim 64 , wherein the cancer is breast cancer.
67 . The method of claim 64 , wherein the cancer is brain cancer.
68 . The method of claim 64 , wherein the cancer is colon cancer.
69 . The method of claim 64 , wherein the cancer is lung cancer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.